168 related articles for article (PubMed ID: 21533296)
21. [Hypomelanosis guttata idiopathica].
Schiller M; Metze D; Böhm M
Hautarzt; 1997 Sep; 48(9):662-5. PubMed ID: 9410853
[TBL] [Abstract][Full Text] [Related]
22. Comprehensive understanding of idiopathic guttate hypomelanosis: clinical and histopathological correlation.
Kim SK; Kim EH; Kang HY; Lee ES; Sohn S; Kim YC
Int J Dermatol; 2010 Feb; 49(2):162-6. PubMed ID: 20465639
[TBL] [Abstract][Full Text] [Related]
23. Progressive macular hypomelanosis in korean patients: a clinicopathologic study.
Hwang SW; Hong SK; Kim SH; Park JH; Seo JK; Sung HS; Lee D
Ann Dermatol; 2009 Aug; 21(3):261-7. PubMed ID: 20523800
[TBL] [Abstract][Full Text] [Related]
24. Progressive macular hypomelanosis is associated with a putative Propionibacterium species.
Relyveld GN; Westerhof W; Woudenberg J; Kingswijk M; Langenberg M; Vandenbroucke-Grauls CM; Bos JD; Savelkoul PH
J Invest Dermatol; 2010 Apr; 130(4):1182-4. PubMed ID: 20043017
[No Abstract] [Full Text] [Related]
25. The use of lymecycline and benzoyl peroxide for the treatment of progressive macular hypomelanosis: a prospective study.
Cavalcanti SM; Querino MC; Magalhães V; França ER; Magalhães M; Alencar E
An Bras Dermatol; 2011; 86(4):813-4. PubMed ID: 21987158
[TBL] [Abstract][Full Text] [Related]
26. Clinical and Histologic Analysis of the Efficacy of Topical Rapamycin Therapy Against Hypomelanotic Macules in Tuberous Sclerosis Complex.
Wataya-Kaneda M; Tanaka M; Yang L; Yang F; Tsuruta D; Nakamura A; Matsumoto S; Hamasaki T; Tanemura A; Katayama I
JAMA Dermatol; 2015 Jul; 151(7):722-30. PubMed ID: 25692384
[TBL] [Abstract][Full Text] [Related]
27. Facial involvement in progressive macular hypomelanosis.
Wang K; Nassef Y; Sahu J; Hermes H; Schwartz LR
Cutis; 2018 Apr; 101(4):297-300. PubMed ID: 29763479
[TBL] [Abstract][Full Text] [Related]
28. Hypomelanosis of Ito: pigmentary mosaicism with immature melanosome in keratinocytes.
Devillers C; Quatresooz P; Hermanns-Lê T; Szepetiuk G; Lemaire R; Piérard-Franchimont C; Piérard GE
Int J Dermatol; 2011 Oct; 50(10):1234-9. PubMed ID: 21950289
[TBL] [Abstract][Full Text] [Related]
29. [Progressive macular hypomelanosis successfully treated with topical clindamycin and benzoyl peroxide].
Echeverría B; Botella-Estrada R; Escutia B; Guillén C
Actas Dermosifiliogr; 2010 Jul; 101(6):565-7. PubMed ID: 20738984
[No Abstract] [Full Text] [Related]
30. [Progressive and confluent macular hypomelanosis].
Rodríguez-Lojo R; Verea MM; Velasco D; Barja JM
Actas Dermosifiliogr; 2010 Apr; 101(3):268-9. PubMed ID: 20398605
[No Abstract] [Full Text] [Related]
31. Hypermelanocytic guttate and macular segmental hypomelanosis.
Westerhof W; Dingemans KP; Hulsmans RF
Br J Dermatol; 2004 Sep; 151(3):701-5. PubMed ID: 15377363
[TBL] [Abstract][Full Text] [Related]
32. Progressive macular hypomelanosis showing excellent response to oral isotretinoin.
Kim YJ; Lee DY; Lee JY; Yoon TY
J Dermatol; 2012 Nov; 39(11):937-8. PubMed ID: 22724575
[No Abstract] [Full Text] [Related]
33. Progressive macular hypomelanosis of the trunk: primary acquired hypopigmentation.
Guillet G; Helenon R; Gauthier Y; Surleve-Bazeille JE; Plantin P; Sassolas B
J Cutan Pathol; 1988 Oct; 15(5):286-9. PubMed ID: 3209765
[TBL] [Abstract][Full Text] [Related]
34. Hypomelanosis of Ito: a case report with clinical and ultrastructural data.
Cellini A; Morroni M; Simonetti O; Offidani A
J Eur Acad Dermatol Venereol; 1998 Jan; 10(1):73-6. PubMed ID: 9552763
[TBL] [Abstract][Full Text] [Related]
35. Progressive macular hypomelanosis Guillet-Hélénon: structural and immunohistochemical findings.
Kuznetsov AV; Flaig MJ; Ruzicka T; Herzinger T
J Clin Pathol; 2011 Aug; 64(8):734-6. PubMed ID: 21490375
[No Abstract] [Full Text] [Related]
36. Pimecrolimus for idiopathic guttate hypomelanosis.
Asawanonda P; Sutthipong T; Prejawai N
J Drugs Dermatol; 2010 Mar; 9(3):238-9. PubMed ID: 20232585
[TBL] [Abstract][Full Text] [Related]
37. Tumor of follicular infundibulum: an unsuspected cause of macular hypopigmentation.
Kubba A; Batrani M; Taneja A; Jain V
Indian J Dermatol Venereol Leprol; 2014; 80(2):141-4. PubMed ID: 24685851
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of topical combination of benzoyl peroxide 5% and clindamycin 1% for the treatment of progressive macular hypomelanosis: a randomized, doubleblind, placebo-controlled trial.
Santos JB; Almeida OL; Silva LM; Barreto ER
An Bras Dermatol; 2011; 86(1):50-4. PubMed ID: 21437522
[TBL] [Abstract][Full Text] [Related]
39. Hypopigmented macules and patches on the extremities of a teenager.
Lawrence H; Shao L; Horii KA
Pediatr Dermatol; 2010; 27(2):197-8. PubMed ID: 20537074
[No Abstract] [Full Text] [Related]
40. Eruptive hypomelanosis: a novel exanthem associated with viral symptoms in children.
Zawar V; Bharatia P; Chuh A
JAMA Dermatol; 2014 Nov; 150(11):1197-201. PubMed ID: 25229328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
